Real-Time Quote
Quote | News | Chart | Details
NOW News & Analysis
Stocks to Watch: RIMM, NKE, F, GS & More
29 Jun 2012 EDT - CNBC.com
Page 2 of 3 | Prev Page | Next Page
Show Entire Article

  • Key Health-Care Stocks Following Supreme Court Ruling
  • Anheuser-Busch InBev - The beer brewer has completed the purchase of the half of Grupo Model that it didn’t already own for $20.1 billion. In a related deal, Constellation Brands bought the 50 percent of Crown Imports that it didn’t already own from AB InBev. Crown had been a joint venture between Constellation and Modelo.

    Royal Bank of Scotland - The bank will reportedly be fined $233 million in connection with the same Libor manipulation probe that saw Barclays assessed $454 million Thursday. That’s according to the Times of London.

    Finish Line - The athletic apparel maker earned $0.24 a year for the first quarter, one cent above estimates. Revenue was essentially in line with consensus.

    Saks - The retailer's shares were upgraded to "overweight" from "neutral" at JPMorgan Chase, with the price target increased to $12 from $11.

    Human Genome Sciences - RBC Capital analyst Michael Yee says the drugmaker could draw a bid worth $15 per share, two dollars higher than the current bid on the table from GlaxoSmithKline.

    Oracle - The stock has been upgraded to "outperform" from "sector perform" at RBC Capital, with the firm citing an accelerated growth outlook for the enterprise software maker.

    —By CNBC’s Peter Schacknow

    Page 2 of 3 | Prev Page | Next Page
    Show Entire Article
    NOW News & Analysis
    No recent news available
    Real-Time Quote
    omniture pixel